Compare VYGR & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYGR | VRA |
|---|---|---|
| Founded | 2013 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.5M | 156.6M |
| IPO Year | 2015 | 2010 |
| Metric | VYGR | VRA |
|---|---|---|
| Price | $1.62 | $5.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $14.22 | N/A |
| AVG Volume (30 Days) | ★ 945.7K | 494.1K |
| Earning Date | 11-05-2026 | 12-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.47 |
| EPS | N/A | ★ N/A |
| Revenue | $10,135,000.00 | ★ $416,097,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $172.11 | $3.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.48 | $1.39 |
| 52 Week High | $5.19 | $8.36 |
| Indicator | VYGR | VRA |
|---|---|---|
| Relative Strength Index (RSI) | 36.85 | 37.70 |
| Support Level | N/A | $2.89 |
| Resistance Level | $2.04 | $8.36 |
| Average True Range (ATR) | 0.15 | 0.62 |
| MACD | 0.01 | -0.25 |
| Stochastic Oscillator | 16.22 | 0.00 |
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
Vera Bradley Inc designs women's handbags, luggage, and travel items, fashion and home accessories, and gifts. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct and Vera Bradley Indirect.